Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6063352 | Journal of Allergy and Clinical Immunology | 2015 | 27 Pages |
Abstract
Subsets of airway MDRCs conclusively discriminate patients with mild asthma, patients with COPD, and healthy subjects from each other. The distinctive activities of these MDRCs in patients with asthma or COPDÂ might provide novel targets for new therapeutics for these common disorders.
Keywords
iNOSDAF-FM-DAnor-NOHAMDSCUABphorbol 12-myristate 13-acetateBALRNSDPINADPHFACSnatural killer4-Amino-5-Methylamino-2′,7′-Difluorofluorescein DiacetatePMAPCAROSChronic obstructive pulmonary diseaseCOPDPrincipal component analysisUniversity of Alabama at Birminghamfluorescence-activated cell sortingDiphenyleneiodoniumSODRegulatory T cellMyeloid cellmyeloid-derived suppressor cellinducible nitric oxide synthaseSuperoxideSuperoxide dismutasebody mass indexBMIbronchoalveolar lavageMacrophageNitric oxidenicotinamide adenine dinucleotide phosphateDHEreactive nitrogen speciesReactive oxygen species
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Jessy S. PhD, David T. PhD, Meiqin MS, Marion L. MS, Jaroslaw W. PhD, John T. MD, Rohit J. BS, Amit MD, PhD, Gene P. MD, PhD, Edward MD, Mark T. MD, David D. MD, PhD,